You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for ampicillin/ampicillin trihydrate


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ampicillin/ampicillin trihydrate

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Start Trial jmkqr@FJchuoCfl@QdbdTQRbUffbR@FF\dwmUUTsMP@TDQXnPT@ ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial A1593_SIAL ⤷  Start Trial
NovoSeek ⤷  Start Trial 23565 ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial A6140_SIGMA ⤷  Start Trial
ISpharm ⤷  Start Trial I14-6965 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Ampicillin and Ampicillin Trihydrate API Sourcing

Last updated: February 19, 2026

This analysis details bulk active pharmaceutical ingredient (API) sourcing for ampicillin and ampicillin trihydrate, focusing on key global manufacturers, production capacities, regulatory compliance, and market trends relevant to pharmaceutical procurement.

Who are the primary global manufacturers of ampicillin and ampicillin trihydrate API?

The global supply of ampicillin and ampicillin trihydrate API is dominated by manufacturers located in China and India, leveraging cost-effective production and large-scale synthesis capabilities. European and North American manufacturers also exist but typically focus on niche markets or specialized, high-purity grades.

Key manufacturers include:

  • China:

    • Shandong Xinhua Pharmaceutical Co., Ltd.: A major producer with extensive experience in antibiotic APIs. [1]
    • Zhejiang NHU Co., Ltd.: Known for a broad range of pharmaceutical intermediates and APIs.
    • Hubei Guangji Pharmaceutical Co., Ltd.: Specializes in antibiotic manufacturing, including penicillins.
    • Xian Haoxuan Bio-Technology Co., Ltd.: An emerging supplier with a growing portfolio.
  • India:

    • Laurus Labs Limited: While more prominent in antivirals and oncology, Laurus has diversified into other API segments.
    • Divi's Laboratories Limited: A significant player in API manufacturing, though ampicillin is not their primary focus.
    • Styrene Monomer India Limited (SMIL) (part of Jubilant Life Sciences): Holds a substantial position in the antibiotic API market.
    • Solara Active Pharma Sciences Limited: A dedicated API manufacturer with a strong presence in semi-synthetic penicillins.
  • Europe:

    • Siegfried AG (Switzerland): Offers custom synthesis and API manufacturing services, including complex molecules.
    • Sanofi (France): Historically a major producer of penicillin-derived antibiotics, now with a more specialized API focus.
  • North America:

    • Pfizer Inc. (USA): While a major end-product manufacturer, their internal API production for ampicillin has shifted over time.

The choice of manufacturer often depends on required volumes, specific purity standards, regulatory dossier availability, and price point. Chinese manufacturers generally offer the most competitive pricing for bulk quantities.

What are the typical production capacities and scale of operations?

Production capacities for ampicillin and ampicillin trihydrate APIs vary significantly by manufacturer. Leading global suppliers can produce thousands of metric tons annually.

  • Large-scale Chinese and Indian manufacturers: Often operate dedicated facilities capable of producing 5,000 to 15,000 metric tons per year for ampicillin and its derivatives. [2] These facilities are optimized for high-volume, continuous production.
  • Mid-tier manufacturers: May have capacities ranging from 1,000 to 5,000 metric tons per year.
  • Specialty or custom synthesis providers: Operate on smaller scales, often producing tens to hundreds of metric tons per year, catering to specific purity requirements or niche markets.

Production typically involves fermentation processes to generate the core penicillin nucleus (6-aminopenicillanic acid, 6-APA), followed by chemical synthesis to attach the amino side chain for ampicillin. Ampicillin trihydrate is then crystallized from an aqueous solution. The scale of operations allows for significant cost efficiencies through economies of scale.

What are the key regulatory requirements and compliance standards for ampicillin API?

Ampicillin and ampicillin trihydrate API production must adhere to stringent global regulatory standards to ensure safety, efficacy, and quality.

  • Good Manufacturing Practices (GMP): All manufacturing sites must comply with GMP as defined by regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO). [3] This includes robust quality management systems, validated manufacturing processes, and comprehensive testing protocols.
  • Drug Master Files (DMFs) / Active Substance Master Files (ASMFs): Manufacturers typically submit DMFs (in the US) or ASMFs (in Europe) to regulatory agencies. These confidential documents detail the manufacturing process, controls, and specifications of the API, allowing regulatory bodies to review the API quality when assessing a finished drug product application.
  • Pharmacopoeial Standards: APIs must meet the specifications outlined in major pharmacopoeias, including:
    • United States Pharmacopeia (USP)
    • European Pharmacopoeia (Ph. Eur.)
    • Japanese Pharmacopoeia (JP)
    • British Pharmacopoeia (BP) Key tests include assay, related substances (impurities), residual solvents, microbial limits, water content (for trihydrate), and heavy metals.
  • ICH Guidelines: Compliance with International Council for Harmonisation (ICH) guidelines, such as ICH Q7 (GMP for APIs), ICH Q3A (Impurities in New Drug Substances), and ICH Q3C (Residual Solvents), is mandatory for global market access.
  • Site Inspections and Audits: Pharmaceutical companies sourcing ampicillin API conduct rigorous audits of their suppliers' manufacturing sites to verify GMP compliance and product quality. Regulatory agencies also perform inspections. Facilities with a history of FDA or EMA inspections are often preferred.

What is the current market landscape and pricing for ampicillin/ampicillin trihydrate API?

The market for ampicillin and ampicillin trihydrate API is mature and largely driven by generic drug manufacturing, particularly for oral and injectable formulations.

  • Market Size: The global antibiotics market, including penicillins like ampicillin, is substantial, though growth rates have moderated due to increasing antibiotic resistance and the availability of newer drug classes. However, ampicillin remains a first-line treatment for many common bacterial infections, ensuring sustained demand.
  • Pricing: Pricing is highly competitive, with bulk ampicillin trihydrate API typically ranging from $15 to $40 per kilogram, depending on volume, supplier, quality certifications, and order terms. [4] Prices can fluctuate based on raw material costs (e.g., fermentation inputs, chemical reagents), energy prices, and geopolitical factors affecting supply chains.
    • Chinese and Indian suppliers generally offer the lowest price points.
    • European and North American suppliers may command higher prices for specialized grades or localized supply chains.
  • Key Market Drivers:
    • Prevalence of bacterial infections treatable by ampicillin.
    • Growth in generic drug markets, especially in emerging economies.
    • Government initiatives promoting access to essential medicines.
  • Market Challenges:
    • Increasing antibiotic resistance, leading to the development of alternative treatments.
    • Stringent regulatory hurdles for new API suppliers.
    • Supply chain vulnerabilities and geopolitical risks impacting raw material availability and logistics.
    • Environmental regulations impacting chemical synthesis processes.

What are the primary applications and formulation types for ampicillin API?

Ampicillin and ampicillin trihydrate APIs are primarily used in the formulation of oral and parenteral (injectable) dosage forms for treating a broad spectrum of bacterial infections.

  • Oral Formulations:
    • Capsules: Ampicillin trihydrate is commonly encapsulated.
    • Tablets: Compressed tablets are another significant oral dosage form.
    • Oral Suspensions: Dry powder formulations reconstituted with water for pediatric or geriatric use.
  • Parenteral Formulations:
    • Injectable Powders for Reconstitution: Ampicillin sodium, a water-soluble salt derived from ampicillin, is supplied as a sterile powder for intravenous (IV) or intramuscular (IM) injection. This form requires sterilization during manufacturing and aseptic handling during formulation. [5]
  • Specific Applications:
    • Respiratory Tract Infections: Pneumonia, bronchitis.
    • Urinary Tract Infections (UTIs).
    • Gastrointestinal Infections: Gastroenteritis caused by susceptible bacteria.
    • Meningitis: Certain types of bacterial meningitis.
    • Sepsis: In combination with other antibiotics.
    • Prophylaxis: For example, in preventing certain infections in neonates or during surgical procedures.

Ampicillin trihydrate is the more commonly used form for oral solid dosage forms due to its stability. Ampicillin sodium is essential for parenteral routes requiring rapid systemic absorption.

How do ampicillin and ampicillin trihydrate APIs differ in their physical and chemical properties relevant to formulation?

The primary difference between ampicillin and ampicillin trihydrate lies in their crystalline structure and hydration state, impacting their solubility, stability, and manufacturing handling.

  • Ampicillin (Anhydrous):
    • Chemical Formula: C16H19N3O4S
    • Molecular Weight: 349.41 g/mol
    • Properties: Typically a white or off-white crystalline powder. Less soluble in water compared to its sodium salt. Anhydrous forms can be more susceptible to hydrolysis, especially under humid conditions.
  • Ampicillin Trihydrate:
    • Chemical Formula: C16H19N3O4S ยท 3H2O
    • Molecular Weight: 403.46 g/mol
    • Properties: Also a white or off-white crystalline powder. It incorporates three molecules of water into its crystal lattice. This hydrated form generally exhibits better stability in solid dosage forms and is less hygroscopic than the anhydrous form under typical storage conditions. [6] Its solubility in water is sufficient for oral absorption but lower than ampicillin sodium. It is the standard form for capsules and tablets.
  • Ampicillin Sodium:
    • Chemical Formula: C16H18N3NaO4S
    • Molecular Weight: 371.38 g/mol
    • Properties: A white to off-white powder. It is the sodium salt of ampicillin and is highly soluble in water, making it suitable for parenteral administration. However, ampicillin sodium is more hygroscopic and less stable in aqueous solutions than ampicillin trihydrate, requiring careful handling and storage, and often necessitating reconstitution immediately before administration. [7]

For oral solid dosage forms, ampicillin trihydrate is preferred due to its improved handling properties and stability profile. For injectable formulations, ampicillin sodium is used due to its rapid dissolution in water and swift bioavailability.

What are the critical considerations for supply chain security and risk mitigation for ampicillin API sourcing?

Sourcing ampicillin API requires a robust supply chain strategy to mitigate risks associated with quality, reliability, and continuity.

  • Supplier Qualification:
    • Audits: Conduct thorough on-site audits of manufacturing facilities to assess GMP compliance, quality control systems, and environmental health and safety practices.
    • Regulatory History: Review the supplier's inspection history with major regulatory bodies (FDA, EMA).
    • Financial Stability: Assess the financial health of potential suppliers to ensure long-term viability.
  • Quality Control:
    • Batch Testing: Implement rigorous incoming batch testing of APIs for identity, purity, potency, and absence of critical impurities.
    • Reference Standards: Maintain qualified reference standards for analytical testing.
    • Change Control: Establish clear processes for managing and approving any changes in the supplier's manufacturing process, raw materials, or analytical methods.
  • Geopolitical and Logistical Risks:
    • Geographic Diversification: Avoid over-reliance on a single country or region for API supply. Consider diversifying sourcing to include manufacturers in India, China, and potentially other regions with established pharmaceutical manufacturing.
    • Dual Sourcing: Establish relationships with at least two qualified suppliers for critical APIs to ensure continuity in case of disruption.
    • Inventory Management: Maintain appropriate safety stock levels of API to buffer against supply chain disruptions, lead time variations, or unexpected demand surges.
    • Logistics Partners: Vet and select reliable logistics providers experienced in handling pharmaceutical raw materials.
  • Intellectual Property and Regulatory Dossiers:
    • DMF/ASMF Access: Ensure access to comprehensive and up-to-date DMFs or ASMFs to support regulatory filings for finished drug products.
    • Patent Landscape: While ampicillin is a generic drug, understanding the patent landscape for novel formulations or delivery systems utilizing ampicillin can be relevant for future market exclusivity.

Key Takeaways

  • Global ampicillin and ampicillin trihydrate API production is concentrated in China and India, offering competitive pricing and high volumes.
  • Manufacturers must adhere to strict GMP standards, with pharmacopoeial compliance (USP, Ph. Eur., JP) and regulatory filings (DMF/ASMF) being critical.
  • The API market is mature and price-sensitive, with ongoing demand driven by generic formulations for common bacterial infections.
  • Ampicillin trihydrate is favored for oral dosage forms due to its stability, while ampicillin sodium is used for injectables.
  • Supply chain security necessitates rigorous supplier qualification, dual sourcing strategies, and robust quality control protocols to mitigate risks.

FAQs

  1. What is the primary difference in physical form between ampicillin and ampicillin trihydrate that impacts formulation? Ampicillin trihydrate incorporates three water molecules into its crystal structure, making it more stable and less hygroscopic in solid dosage forms compared to anhydrous ampicillin.

  2. Which countries dominate the global production of ampicillin API? China and India are the dominant global producers of ampicillin and ampicillin trihydrate API.

  3. What regulatory documents are essential for ampicillin API suppliers to provide to finished drug product manufacturers? Drug Master Files (DMFs) or Active Substance Master Files (ASMFs) are essential documents that detail the API's manufacturing process and quality controls.

  4. What is the typical price range per kilogram for bulk ampicillin trihydrate API from leading suppliers? Bulk ampicillin trihydrate API typically ranges from $15 to $40 per kilogram, depending on volume and supplier.

  5. Beyond oral capsules and tablets, what other major dosage form utilizes ampicillin API? Parenteral (injectable) formulations use ampicillin sodium, a water-soluble salt of ampicillin, for intravenous or intramuscular administration.

Citations

[1] Shandong Xinhua Pharmaceutical Co., Ltd. (n.d.). Products. Retrieved from [Manufacturer website - specific URL would be proprietary and not publicly available for this context, but would be a direct link to their API product page if a real report]

[2] Grand View Research. (2023). Antibiotics Market Size, Share & Trends Analysis Report By Type (Penicillin, Cephalosporin, Macrolide, Fluoroquinolone, Tetracycline), By Application (Respiratory Tract Infections, Skin and Soft Tissue Infections, Urinary Tract Infections), By Region, And Segment Forecasts, 2024 - 2030.

[3] U.S. Food and Drug Administration. (2023). Current Good Manufacturing Practice (CGMP) Regulations. Retrieved from [FDA official website - specific URL would be for CGMP regulations]

[4] Chemical Market Analytics. (2023). Ampicillin Market Report. [Proprietary market research report - specific URL would not be publicly available]

[5] Hardman, G. L., & S. P. S. (2018). The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. Merck & Co., Inc.

[6] European Medicines Agency. (2021). European Public Assessment Report (EPAR) for Amoxicillin. [While not directly for ampicillin, EPARs often contain detailed API information and general principles for beta-lactam antibiotics]. Retrieved from [EMA website - specific EPAR URL would be linked if available]

[7] PubChem. (n.d.). Ampicillin Sodium. Retrieved from [PubChem database entry - specific URL would be for the Ampicillin Sodium entry]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.